Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
sortieren
Medicine and Dentistry
Biliary Tract Cancer
75%
Overall Survival
75%
Targeted Therapy
70%
Molecular Profiling
70%
Diseases
70%
Biliary Duct Cancer
60%
Miliary Tuberculosis
50%
Acute Myeloid Leukemia
50%
Venetoclax
50%
Azacitidine
50%
Hepatobiliary System
50%
Real-World Data
50%
Pancreas Adenocarcinoma
50%
Colorectal Carcinoma
50%
Adjuvant Therapy
50%
Cancer
50%
Cholangiocarcinoma
50%
Rifampicin
33%
Recombination Repair
30%
Homologous Recombination
30%
Liquid Biopsy
25%
Minimal Residual Disease
25%
Fluoropyrimidine
25%
Treatment Option
25%
Gallbladder Carcinoma
25%
Circulating Tumor DNA
25%
Precision Oncology
25%
Gene Mutation
25%
Immunotherapy
25%
Fibroblast Growth Factor Receptor 2
20%
CYP3A4
16%
Ethambutol
16%
Intestine Perforation
16%
Adverse Event
16%
Pyrazinamide
16%
Isoniazid
16%
Neutropenia
16%
Gastrointestinal Oncology
10%
Fusion Gene
10%
DNA Methyltransferase 3A
10%
Personalized Medicine
10%
Irinotecan Sucrosofate
10%
Patient Population
10%
Oxaliplatin
10%
Subgroup Analysis
10%
Fluorouracil
10%
Folinic Acid
10%
Paclitaxel
10%
Chemotherapy
10%
Retrospective Study
10%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Colorectal Cancer
100%
Diseases
78%
Overall Survival
66%
Colorectal Carcinoma
66%
Immunotherapy
50%
Tipiracil
50%
Trifluridine
50%
Immune Checkpoint Inhibitor
50%
Miliary Tuberculosis
50%
Pancreas Adenocarcinoma
50%
Bevacizumab
50%
Acute Myeloid Leukemia
50%
Azacitidine
50%
Venetoclax
50%
Chemotherapy
35%
Rifampicin
33%
Remission
33%
Fluoropyrimidine
25%
Minimal Residual Disease
25%
Circulating Tumor DNA
25%
Combination Therapy
16%
Ethambutol
16%
Biological Marker
16%
CYP3A4
16%
Neutropenia
16%
Adverse Event
16%
Intestine Perforation
16%
Isoniazid
16%
Pyrazinamide
16%
Retrospective Study
10%
Fluorouracil
10%
Irinotecan Sucrosofate
10%
Oxaliplatin
10%
Gemcitabine
10%
Folinic Acid
10%
Paclitaxel
10%
Malignant Neoplasm
8%
Monotherapy
8%
